ArticleOncotarget2017
The implication from RAS/RAF/ERK signaling pathway increased activation in epirubicin treated triple negative breast cancer.
Jianbo Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papercites it